Objective: HIV-1 is characterized by a high degree of genetic variation and
can be divided into at least 10 distinct genetic subtypes. The purpose of
this study was to investigate whether the rate of disease progression shows
subtype-specific differences.
Design: The investigation was divided into two parts; one study in which 49
ethnic Africans were compared with 49 ethnic Swedes irrespective of the su
btype of the infecting virus, and a second study in which 126 individuals i
nfected with different genetic subtypes (28 with subtype A, 59 with subtype
B, 21 with subtype C and 18 with subtype D) were compared.
Methods: CD4 cell counts, the rate of CD4 cell decline, plasma HIV-1 RNA le
vels, clinical status and antiviral treatment were prospectively and retros
pectively recorded. The HIV-1 subtype had previously been determined by dir
ect sequencing of the V3 domain of the env gene.
Results: There were no significant differences in the rate of CD4 cell decl
ine or clinical disease progression between Africans and Swedes over an obs
ervation period of 2 years. Similarly, there were no differences in the rat
e of CD4 cell decline, clinical progression or plasma HIV-1 RNA levels betw
een individuals infected with subtypes A, B, C or D over a mean observation
period of 44 months.
Conclusion: Neither the genetic subtype of the virus nor the ethnicity of t
he host appear to be major determinants of disease progression. (C) 1999 Li
ppincott Williams & Wilkins.